BR0109934A - Preparação e prevenção de diarréia de ácido biliar - Google Patents

Preparação e prevenção de diarréia de ácido biliar

Info

Publication number
BR0109934A
BR0109934A BR0109934-5A BR0109934A BR0109934A BR 0109934 A BR0109934 A BR 0109934A BR 0109934 A BR0109934 A BR 0109934A BR 0109934 A BR0109934 A BR 0109934A
Authority
BR
Brazil
Prior art keywords
bile acid
prevention
preparation
acid diarrhea
diarrhea
Prior art date
Application number
BR0109934-5A
Other languages
English (en)
Inventor
Kazuyoshi Masuda
Katsuji Sugita
Hiroshi Hayakawa
Hidekazu Syodai
Yusuke Suzuki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of BR0109934A publication Critical patent/BR0109934A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PREPARAçãO E PREVENçãO DE DIARRéIA DE áCIDO BILIAR". Preparações para a prevenção de diarréia de ácido biliar que compreendem conter um adsorvente de ácido biliar com um polímero a fim de permitir a sua liberação ao redor de uma área desde a parte inferior do intestino delgado até o ceco; e composições farmacêuticas compreendendo uma combinação de inibidores de reabsorção de ácido biliar com as preparações acima para a prevenção de diarréia de ácido biliar (por exemplo, agente anti-hiperlipidêmico.
BR0109934-5A 2000-04-10 2001-03-29 Preparação e prevenção de diarréia de ácido biliar BR0109934A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000107431 2000-04-10
PCT/JP2001/002618 WO2001076635A1 (en) 2000-04-10 2001-03-29 Preparations for preventing bile acid diarrhea

Publications (1)

Publication Number Publication Date
BR0109934A true BR0109934A (pt) 2003-05-27

Family

ID=18620426

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109934-5A BR0109934A (pt) 2000-04-10 2001-03-29 Preparação e prevenção de diarréia de ácido biliar

Country Status (11)

Country Link
US (1) US20030124088A1 (pt)
EP (1) EP1273307A1 (pt)
KR (1) KR20030008367A (pt)
CN (1) CN1198653C (pt)
AU (2) AU4461101A (pt)
BR (1) BR0109934A (pt)
CA (1) CA2404422A1 (pt)
MX (1) MXPA02009897A (pt)
TW (1) TWI241195B (pt)
WO (1) WO2001076635A1 (pt)
ZA (1) ZA200208310B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2637020T3 (es) * 2001-04-18 2017-10-10 Genzyme Corporation Uso de polímero de amina para reducir la glucosa sérica
JP2007517047A (ja) * 2003-12-31 2007-06-28 ジェンザイム・コーポレーション 腸溶コーティングされた脂肪族アミンポリマーの胆汁酸捕捉因子
NZ595865A (en) * 2005-10-07 2011-12-22 Colocaps Pty Ltd Preparation for the Treatment of Diarrhoea comprising a bulking agent and diphenoxylate (ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
EP1949093A2 (en) * 2005-10-11 2008-07-30 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
EP3777864A1 (en) 2010-11-04 2021-02-17 Albireo AB Ibat inhibitors for the treatment of liver diseases
WO2015199147A1 (ja) 2014-06-25 2015-12-30 味の素株式会社 固形製剤及びその着色防止又は着色低減方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
WO2017138878A1 (en) 2016-02-09 2017-08-17 Albireo Ab Oral cholestyramine formulation and use thereof
EP3413875B1 (en) 2016-02-09 2020-01-29 Albireo AB Cholestyramine pellets and methods for preparation thereof
WO2019032027A1 (en) 2017-08-09 2019-02-14 Albireo Ab CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
JP2020530448A (ja) * 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
CA3089742A1 (en) * 2018-01-30 2019-08-08 Pharmascience Inc. Cholestyramine formulations and methods of use
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
IL279464B2 (en) 2018-06-20 2025-12-01 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11590161B2 (en) 2018-08-13 2023-02-28 Viscera Labs, Inc. Therapeutic composition and methods
US11524029B2 (en) 2018-08-13 2022-12-13 Viscera Labs, Inc. Therapeutic composition and methods
KR102447441B1 (ko) 2019-04-15 2022-09-27 (주)제테마 보툴리눔 독소의 정제방법
KR102516204B1 (ko) 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914401A (en) * 1971-10-12 1975-10-21 Lilly Co Eli Enteric compositions
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory
ZA876640B (en) * 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
ATE175954T1 (de) * 1991-10-17 1999-02-15 Shionogi & Co Verfahren zum herstellen von lignin-analoga und ausgangsprodukte dafür
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JPH09241206A (ja) * 1996-03-01 1997-09-16 Shionogi & Co Ltd リグナン系化合物

Also Published As

Publication number Publication date
CN1422164A (zh) 2003-06-04
AU2001244611B2 (en) 2006-02-16
KR20030008367A (ko) 2003-01-25
CN1198653C (zh) 2005-04-27
WO2001076635A1 (en) 2001-10-18
US20030124088A1 (en) 2003-07-03
AU4461101A (en) 2001-10-23
TWI241195B (en) 2005-10-11
EP1273307A1 (en) 2003-01-08
CA2404422A1 (en) 2002-09-26
ZA200208310B (en) 2003-10-15
MXPA02009897A (es) 2003-03-27

Similar Documents

Publication Publication Date Title
BR0109934A (pt) Preparação e prevenção de diarréia de ácido biliar
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
WO2003022252A3 (en) Combinatorial type (several vehicles within a housing) controlled release drug delivery device
IL117144A0 (en) Pharmaceutical compositions containing nucleic acids
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
BR0307893A (pt) Formulação oftálmica com sistema de goma
EP1731140A3 (en) Medicinal aerosol formulation
EP2266590A3 (en) Active agent delivery sytems and methods for protecting and administering active agents
BR0008911A (pt) Bactérias patogênicas da cepa lactobacillus para a prevenção de diarréia
CA2346001A1 (en) Controlled release nanoparticulate compositions
BR0208183A (pt) Peptìdeo modificado por wt1
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
EP0871435A4 (en) THREE DIFFERENT FORMULATION OF POLYMERS WITH DELAYED RELEASE
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
NO20002741D0 (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
CA2416403A1 (en) A medicinal aerosol formulation
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
WO2002051424A8 (en) Drugs against articular failure
BR9910639A (pt) Drogas anti-angiogênicas compreendendo peptìdeo
BR0003987A (pt) Composição laxativa
NZ501950A (en) Medicinal compositions for application to mucosa
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
BR9813514A (pt) Agente para tratamento de fibras queratìnicas

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.